Literature DB >> 2827114

Specific nuclear proteins interact with the Rous sarcoma virus internal enhancer and share a common element with the enhancer located in the long terminal repeat of the virus.

L Karnitz1, S Faber, R Chalkley.   

Abstract

We have documented that the Rous sarcoma virus (RSV) internal enhancer functions in the nontransformed Baby Hamster Kidney (BHK) cell line. The sequences within this region were assayed for their ability to bind to specific factors present in BHK nuclear extracts using the gel retardation assay and DNAse I footprinting. At least two sequences within the internal enhancer which can specifically bind nuclear factors in vitro have been identified. These regions are located between nucleotides 813-850 and 856-877. These sites map within the overall region of the internal enhancer which has been shown to be essential for enhancer activity and within the specific region which can function as an orientation independent enhancer. Using the DNase I footprinting and binding data to design an oligonucleotide, we have demonstrated that an oligonucleotide extending from nucleotides 804-877 will substitute efficiently as an enhancer. We also demonstrate that the SV40 enhancer does not compete for the factors which bind to the RSV internal enhancer, whereas an oligonucleotide to the binding site for EFII in the LTR can compete for factor binding to the internal enhancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827114      PMCID: PMC306535          DOI: 10.1093/nar/15.23.9841

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  cis-acting regulatory elements within gag genes of avian retroviruses.

Authors:  S Arrigo; M Yun; K Beemon
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

4.  Structure of viral DNA and RNA in mammalian cells infected with avian sarcoma virus.

Authors:  N Quintrell; S H Hughes; H E Varmus; J M Bishop
Journal:  J Mol Biol       Date:  1980-11-15       Impact factor: 5.469

5.  Fine structure of the origin-proximal DNAase I-hypersensitive region in wild-type and EC mutant polyoma.

Authors:  P Herbomel; S Saragosti; D Blangy; M Yaniv
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA.

Authors:  S Saragosti; G Moyne; M Yaniv
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

8.  An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA.

Authors:  N D Stow; N M Wilkie
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

9.  Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements.

Authors:  R Swanstrom; W J DeLorbe; J M Bishop; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system.

Authors:  M M Garner; A Revzin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

View more
  8 in total

1.  Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.

Authors:  J T Miller; C M Stoltzfus
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  A transformation-competent recombinant between v-src and Rous-associated virus RAV-1.

Authors:  J Svoboda; J C Kandala; J Geryk; J Pichrtová; R V Guntaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Purification and properties of the Rous sarcoma virus internal enhancer binding factor.

Authors:  L Karnitz; D Poon; P A Weil; R Chalkley
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

4.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  The putative trans-activator in the MAgag region of Rous sarcoma virus is not required for cell transformation.

Authors:  A Dutta; T Dorai; H Hanafusa
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein.

Authors:  T A Ryden; K Beemon
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

7.  Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.

Authors:  R C Sears; L Sealy
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Mutation of the C/EBP binding sites in the Rous sarcoma virus long terminal repeat and gag enhancers.

Authors:  T A Ryden; M de Mars; K Beemon
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.